Saturday, April 10, 2021 7:03:52 AM
Recent CELC News
- Celcuity To Present at Upcoming Needham and Stifel Investor Conferences • GlobeNewswire Inc. • 04/04/2024 11:05:00 AM
- Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/27/2024 08:01:00 PM
- Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call • GlobeNewswire Inc. • 03/20/2024 11:05:00 AM
- Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024 • GlobeNewswire Inc. • 03/06/2024 12:05:00 PM
- Celcuity to Participate in Cowen’s 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/28/2024 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:43:40 PM
- Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer • GlobeNewswire Inc. • 02/22/2024 09:05:00 PM
- Celcuity Appoints Eldon Mayer as Chief Commercial Officer • GlobeNewswire Inc. • 02/20/2024 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:25:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:24:05 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/15/2024 01:28:41 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:05:37 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 03:32:58 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/07/2024 10:15:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:09:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/20/2023 03:34:44 PM
- Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposium • GlobeNewswire Inc. • 12/06/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 10:25:33 PM
- Celcuity to Present Preclinical Data for Gedatolisib at the 2023 San Antonio Breast Cancer Symposium • GlobeNewswire Inc. • 12/01/2023 04:02:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/30/2023 09:12:16 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/29/2023 09:30:52 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/29/2023 05:15:11 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 01:15:46 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM